ciclopirox NDC 71335-2757

NDC codes

FDA NDC Directory

Product NDC (as listed)71335-2757Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71335-2757Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
71335-2757-1	71335275701	30 g in 1 TUBE (71335-2757-1)Marketed from Aug 8, 2025

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): ciclopirox
Generic name (nonproprietary): ciclopirox
Active ingredients: Ciclopirox — 7.7 mg/g
Dosage form: Gel
Route: Topical
Labeler: Bryant Ranch Prepack
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 091595
Marketing start: Feb 29, 2012
Listing expires: Dec 31, 2026
Other FDA classes: Decreased DNA Replication (Physiologic effect)Decreased Protein Synthesis (Physiologic effect)Decreased RNA Replication (Physiologic effect)Protein Synthesis Inhibitors (Mechanism)
Identifiers: Product ID 71335-2757_f12c1396-d3e6-46a4-b8b3-2cf17dc17f06SPL ID f12c1396-d3e6-46a4-b8b3-2cf17dc17f06SPL set ID 810bfb01-a69d-4b00-ac2d-b92e7ddad9f9RxCUI 313941UNII 19W019ZDRJ

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471335275701 followed by a unit qualifier and the quantity

Package 71335-2757-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 8, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Superficial Dermatophyte Infections Ciclopirox gel is indicated for the topical treatment of interdigital tinea pedis and tinea corporis due to Trichophyton rubrum, Trichophyton mentagrophytes, or Epidermophyton floccosum . Seborrheic Dermatitis Ciclopirox gel is indicated for the topical treatment of seborrheic dermatitis of the scalp.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 091595

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 091595
Product	Strength	Form · route	Labeler	Product NDC
ciclopirox	Ciclopirox 7.7 mg/g	GelTopical	Glenmark Pharmaceuticals Inc., USA	68462-455